Contact Dermatitis - Pipeline Review, H2 2017

Publisher Name :
Date: 12-Sep-2017
No. of pages: 52
Inquire Before Buying

Contact Dermatitis - Pipeline Review, H2 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Contact Dermatitis - Pipeline Review, H2 2017, provides an overview of the Contact Dermatitis (Dermatology) pipeline landscape.

Contact dermatitis is a type of skin inflammation that occurs when substances touching skin cause irritation or an allergic reaction. Signs and symptoms of contact dermatitis include red rash or bumps, dry, cracked, red patches, which may resemble a burn and pain or tenderness. There are two types of contact dermatitis; irritant and allergic. Irritant dermatitis, the most common type, is caused by contact with acids, alkaline materials such as soaps and detergents, fabric softeners, solvents, or other chemicals. The reaction usually looks like a burn. Allergic contact dermatitis is an itchy skin condition caused by an allergic reaction to allergen. Treatment includes oral corticosteroids and antihistamines to relieve intense itching.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Contact Dermatitis - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Contact Dermatitis (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Contact Dermatitis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Contact Dermatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I and Preclinical stages are 3, 3 and 6 respectively.

Contact Dermatitis (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Contact Dermatitis (Dermatology).

- The pipeline guide reviews pipeline therapeutics for Contact Dermatitis (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Contact Dermatitis (Dermatology) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Contact Dermatitis (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Contact Dermatitis (Dermatology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Contact Dermatitis (Dermatology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Contact Dermatitis (Dermatology) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Contact Dermatitis - Pipeline Review, H2 2017

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Contact Dermatitis - Overview
Contact Dermatitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Contact Dermatitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Contact Dermatitis - Companies Involved in Therapeutics Development
Brickell Biotech Inc
Dr. August Wolff GmbH & Co KG Arzneimittle
NeuroCycle Therapeutics GmbH
Novartis AG
Pfizer Inc
RaQualia Pharma Inc
Contact Dermatitis - Drug Profiles
AAT-008 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AN-3485 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BBI-2000 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EB-01 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EB-05 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
grapiprant - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HPT-721 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NCT-10004 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pertussis [strain BPZE1] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
secukinumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SIG-1322 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
WOL-071007 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Contact Dermatitis - Dormant Projects
Contact Dermatitis - Discontinued Products
Contact Dermatitis - Product Development Milestones
Featured News & Press Releases
Nov 19, 2015: Hapten Sciences to Begin Clinical Trials for Novel Poison Ivy Vaccine
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Contact Dermatitis, H2 2017
Number of Products under Development by Companies, H2 2017
Products under Development by Companies, H2 2017
Number of Products by Stage and Target, H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Contact Dermatitis - Pipeline by Brickell Biotech Inc, H2 2017
Contact Dermatitis - Pipeline by Dr. August Wolff GmbH & Co KG Arzneimittle, H2 2017
Contact Dermatitis - Pipeline by NeuroCycle Therapeutics GmbH, H2 2017
Contact Dermatitis - Pipeline by Novartis AG, H2 2017
Contact Dermatitis - Pipeline by Pfizer Inc, H2 2017
Contact Dermatitis - Pipeline by RaQualia Pharma Inc, H2 2017
Contact Dermatitis - Dormant Projects, H2 2017
Contact Dermatitis - Discontinued Products, H2 2017

List of Figures
Number of Products under Development for Contact Dermatitis, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products by Targets, H2 2017
Number of Products by Stage and Targets, H2 2017
Number of Products by Mechanism of Actions, H2 2017
Number of Products by Stage and Mechanism of Actions, H2 2017
Number of Products by Routes of Administration, H2 2017
Number of Products by Stage and Routes of Administration, H2 2017
Number of Products by Molecule Types, H2 2017
Number of Products by Stage and Molecule Types, H2 2017
  • Global Hyaluronic Acid Based Dermal Fillers Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 16-Jun-2018        Price: US 3480 Onwards        Pages: 146
    Hyaluronic Acid Based Dermal Fillers are the product can be used to smooth away wrinkles and fine line, create fuller and more accentuated lips, and adding facial volume and contour. Scope of the Report: This report focuses on the Hyaluronic Acid Based Dermal Fillers in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Hyaluronic Acid Based Dermal Fillers Market 2018, Forecast to 2023
    Published: 16-Jun-2018        Price: US 4880 Onwards        Pages: 154
    Hyaluronic Acid Based Dermal Fillers are the product can be used to smooth away wrinkles and fine line, create fuller and more accentuated lips, and adding facial volume and contour. Scope of the Report: This report focuses on the Hyaluronic Acid Based Dermal Fillers in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.......
  • Global Dermatology Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Jun-2018        Price: US 3480 Onwards        Pages: 129
    Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Scope of the Report: This report focuses on the Dermatology Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The classification of Dermatology Drug includes Externa......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Dermatology Drug Market 2018, Forecast to 2023
    Published: 14-Jun-2018        Price: US 4880 Onwards        Pages: 136
    Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Scope of the Report: This report focuses on the Dermatology Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The classification of Dermatology Drug includes Externa......
  • The Global Dermatology Market to 2028
    Published: 03-Jun-2018        Price: US 2501 Onwards        Pages: 180
    The global dermatological (prescription) drugs market was valued at $38.4bn in 2017, GMR Data forecast that this will rise to $44.1bn across 2018.The third in a series of biennial Dermatology reports sees GMR Data again interview industry experts to produce a market leading report that dissects and investigates the key questions in the Global Dermatology Market across the next decade. GMR Data forecasts that the global dermatology (prescription) drugs market will report a ......
  • Global Dermatology Drug Market Research Report 2018
    Published: 01-Jun-2018        Price: US 2900 Onwards        Pages: 94
    This report studies the global Dermatology Drug market status and forecast, categorizes the global Dermatology Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. The classificatio......
  • Global Onychomycosis (Tinea Unguium) Drug Sales Market Report 2018
    Published: 01-Jun-2018        Price: US 4000 Onwards        Pages: 103
    In this report, the global Onychomycosis (Tinea Unguium) Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Onychomycosis (Tinea Unguium) Drug for these regions, from 2012 to 2022 (forecast), covering - United States - China......
  • Global Onychomycosis (Tinea Unguium) Drug Market Research Report 2018
    Published: 31-May-2018        Price: US 2900 Onwards        Pages: 90
    This report studies the global Onychomycosis (Tinea Unguium) Drug market status and forecast, categorizes the global Onychomycosis (Tinea Unguium) Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Onychomycosis (Tinea Unguium) Drug market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025......
  • China Drugs for Warts Market Research Report 2018
    Published: 31-May-2018        Price: US 3400 Onwards        Pages: 102
    The global Drugs for Warts market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Drugs for Warts development status and future trend in China, focuses on top players in China, also splits Drugs for Wart......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs